We use cookies to improve your experience on this website. Read More Allow Cookies



The theme of this research is drug delivery with an emphasis on products of the pharmaceutical biotechnology industry including peptide/protein type drugs, plasmid DNA and siRNA. Biopharmaceuticals, including peptide/proteins and nucleic acids, which are now approaching 50% of all new drugs in development.

It is well accepted that the major barrier to translating these product into the clinic is the design of efficient, non-toxic delivery systems. Thus the focus of Prof O’Driscoll’s research is the development of nano-sized delivery constructs which are robust enough to survive processing, are stable on storage and achieve cell /site specific delivery in vivo. 

Such targeted systems aim to increase therapeutic efficacy and reduce side effects thus ensuring improved patient outcomes.